UNSPSC 85532266: Bypass left greater saphenous vein to lower vein with nonautologous tissue substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to bypass left greater saphenous vein to lower vein with nonautologous tissue substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 061Q4KY

UNSPSC 85532266 "Bypass left greater saphenous vein to lower vein with nonautologous tissue substitute, percutaneous endoscopic approach" is a Commodity code that shows little relevant recent activity. The code appears to describe a specific surgical procedure, but the recent state and local opportunities tagged to it are administrative and operational health services unrelated to vascular surgery: independent medical evaluations for disability pension determinations, pharmacy benefit management, surgical procedure carve-out benefit programs, occupational medical surveillance, specialty medical services for detained youth, and temporary health professional staffing. None of these opportunities involve vascular grafting, prosthetic tissue substitutes, or the endoscopic vein bypass procedure the code nominates. The mismatch suggests either systematic miscoding in the state and local procurement system or that the code is not actively used for purchasing actual surgical services or devices at the state and local level.

The issuing bodies in the recent-opportunities block span city retirement offices (City of Phoenix), municipal employee benefits programs (City of Long Beach), state transportation agencies (Washington State Department of Transportation), county health systems (Santa Clara, Collier County, Harris County), and county probation departments. Geographic representation includes Arizona, California, Washington, and Texas. No repeat solicitations under this code appear in the sample, and no opportunities directly solicit surgical procedures, prosthetic devices, tissue products, or supplies that would map to the code's nominal scope.